News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Rocket Lab completed its 96th Electron launch successfully.
  • The mission deployed Synspective's 12th StriX SAR satellite into low Earth orbit.
  • It was Rocket Lab's 17th launch of 2026.
  • Rocket Lab plans 15 more dedicated Electron launches to complete Synspective's commercial SAR constellation by decade's end.
  • BP is recommended as a buy for income investors.
  • BP's dividend yield is about 4.4%.
  • BP's market capitalization is roughly $116 billion, with valuation seen as leaving room for mid-term upside.

Latest Articles

Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures’ Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation

Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures’ Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation

CSN's subsidiary, CSN Inova Ventures, initiates a private exchange offer for its outstanding 6.750% Senior Notes due 2028, allowing eligible holders to exchange these notes for new 11.000% Senior Notes due 2030 plus cash. The offer includes a consent solicitation for amendments to the 2028 notes indenture. Key conditions include a required minimum …

Tesla Weighs Options for China Unit as Musk Mulls Possible SpaceX Tie-Up

Tesla Weighs Options for China Unit as Musk Mulls Possible SpaceX Tie-Up

Tesla has internally examined separating its China operations as CEO Elon Musk entertains the prospect of combining Tesla with SpaceX. Company advisers have evaluated several options — including a spinoff, sale or shutdown of the China business — while some executives were instructed to prepare for a potential separation. Market reaction included a…

Yen Intervention Pulls USD/JPY Lower: Domestic Stocks Positioned to Benefit

Yen Intervention Pulls USD/JPY Lower: Domestic Stocks Positioned to Benefit

On Jul 30, 2026 Japan reportedly intervened in currency markets, conducting coordinated yen purchases with possible U.S. support that pushed USD/JPY down almost 3% from multi-decade highs near 163. While exporters face renewed margin pressure, sectors that import commodities, energy and inputs priced in dollars - notably utilities, airlines and rai…

North Korea Warns U.S. Forces Japan Expansion Raises Prospect of Peninsula Clash

North Korea Warns U.S. Forces Japan Expansion Raises Prospect of Peninsula Clash

North Korean state media criticized the growth of the U.S. Forces Japan headquarters and allied military cooperation, saying the expansion makes a clash on the Korean Peninsula a matter of timing. The commentary followed U.S. Forces Japan commander Lt. Gen. Stephen Jost’s confirmation of a 215-personnel increase to strengthen command functions and …

Tech Earnings Lift Futures as Amazon Climbs and Apple Tumbles

Tech Earnings Lift Futures as Amazon Climbs and Apple Tumbles

U.S. stock index futures moved higher on Thursday evening after a strong session on Wall Street, driven by upbeat earnings from Amazon and Microsoft that supported technology names and chipmakers. Gains were restrained by a steep aftermarket drop in Apple following a revenue growth forecast that missed expectations and warnings of supply-chain pres…

Cuba Details Program to Open State-Dominated Sectors as U.S. Pressure Mounts

Cuba Details Program to Open State-Dominated Sectors as U.S. Pressure Mounts

Cuba unveiled expanded plans to permit greater private participation in targeted state-controlled industries as U.S. sanctions and an oil blockade intensify pressure on the economy. Lawmakers discussed measures to ease land-use rules, let businesses import fuel and medicine, and allow private tourist operators. Officials emphasized the changes will…

Churchill Capital Corp XIII Prices $360 Million IPO on Nasdaq Global Market

Churchill Capital Corp XIII Prices $360 Million IPO on Nasdaq Global Market

Churchill Capital Corp XIII has priced an upsized initial public offering of 36,000,000 units at $10.00 per unit, generating $360 million. The units are trading on the Nasdaq Global Market as XIIIU and include a Class A ordinary share and one-tenth of a redeemable warrant. The offering is expected to close on August 3, 2026, subject to customary cl…

Trump Says Board of Peace Secures Deal for Hamas Disarmament in Gaza

Trump Says Board of Peace Secures Deal for Hamas Disarmament in Gaza

U.S. President Donald Trump announced that his so-called 'Board of Peace' has reached an agreement calling for the complete disarmament of Hamas and other armed groups in Gaza. The plan, described as a milestone in the implementation of the Trump 20-Point Plan, envisions phased disarmament, Israeli troop withdrawals, and an International Stabilizat…

Telix H1 2026 Results: Investor Webcast Notification

Telix H1 2026 Results: Investor Webcast Notification

Telix Pharmaceuticals Limited will release its financial results for the half-year ended June 30, 2026, on August 20, 2026, accompanied by an investor webcast and conference call. The company is a commercial-stage global radiopharmaceutical firm focused on targeted theranostics for cancer treatment and diagnosis, with an established prostate cancer…

Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Replimune Group, Inc. announced a favorable outcome from the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee regarding the Biologics License Application resubmission for RP1, an oncolytic immunotherapy, used in combination with nivolumab to treat advanced melanoma patients who progressed after prior anti-PD-1 therapy. The committee vo…